14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
FRSX vs CRNT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Foresight Autonomous Holdings Ltd. (FRSX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FRSX carries a Unified Composite Score of 47.2/100 (HOLD) at $0.55 (N/M Forward P/E, -2642.2% operating margin), whereas CRNT carries 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin).
Composite vs. Pillar Nuance: While FRSX currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -2642.2% operating margin) and revenue trajectory (+11.7% vs. -32.8% YoY).
Technical & Structure Timing Caution: FRSX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.8); meanwhile CRNT is in a Breakdown options structure phase (RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FRSX vs CRNT. Trailing 12-month operating profitability (FRSX -2642.2% vs CRNT 3.5%) and valuation multiples (FRSX N/M vs CRNT 13.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Communication Equipment value chain with $217.2M market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment30.6% of Rev ($109M)
90D Engineering Disclosures0 Published
Investor FAQ FRSX vs CRNT Key Questions & Quantitative Answers
As of Nov 16, 2026, Ceragon Networks Ltd (CRNT) is the stronger overall head-to-head candidate over Foresight Autonomous Holdings Ltd. (FRSX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FRSX carries a Unified Composite Score of 47.2/100 (HOLD) at $0.55 (N/M Forward P/E, -2642.2% operating margin), whereas CRNT carries 26.6/100 (SELL) at $2.36 (13.7x Forward P/E, 3.5% operating margin). Composite vs. Pillar Nuance: While FRSX currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CRNT 26.6/100 SELL), CRNT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (3.5% vs. -2642.2% operating margin) and revenue trajectory (+11.7% vs. -32.8% YoY). Technical & Structure Timing Caution: FRSX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.8); meanwhile CRNT is in a Breakdown options structure phase (RSI 56.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CRNT leads the Growth & Scale pillar: FRSX posts -32.8% YoY revenue growth and +0.0% YoY earnings growth on $445,000 TTM revenue (65.4% gross margin, -2642.2% operating margin), compared with CRNT at +11.7% YoY revenue growth and N/A YoY earnings growth on $357M TTM revenue (34.1% gross margin, 3.5% operating margin). On trailing 12-month operating scale, FRSX generates $445,000 in USD-normalized revenue versus $357M for CRNT. In operating R&D and SG&A reinvestment, FRSX deploys N/A (0 90-day corporate R&D disclosures) versus 30.6% of Rev ($109M) (0 disclosures) for CRNT.
CRNT screens cheaper on headline valuation multiples. FRSX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 5.2x EV/Revenue (unreported EBITDA margin), whereas CRNT trades at 13.7x Forward P/E, 15.7x Trailing P/E, 8.80x PEG, and 0.6x EV/Revenue (3.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FRSX (-205.9% ROE) versus CRNT (-0.5% ROE) capital efficiency.
In options market volatility and institutional positioning, FRSX carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 53% Vol realized risk). By comparison, CRNT carries 43.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.84β · 77% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.